UK markets closed

Stoke Therapeutics, Inc. (STOK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
12.41+0.72 (+6.16%)
At close: 04:00PM EDT
12.08 -0.33 (-2.66%)
After hours: 07:28PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 646.78M
Enterprise value 447.45M
Trailing P/E 21.65
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)62.18
Price/book (mrq)4.05
Enterprise value/revenue 50.96
Enterprise value/EBITDA -3.98

Trading information

Stock price history

Beta (5Y monthly) 0.76
52-week change 325.73%
S&P500 52-week change 322.36%
52-week high 316.40
52-week low 33.35
50-day moving average 39.27
200-day moving average 36.15

Share statistics

Avg vol (3-month) 31.21M
Avg vol (10-day) 31.08M
Shares outstanding 552.12M
Implied shares outstanding 652.12M
Float 835.51M
% held by insiders 14.64%
% held by institutions 181.16%
Shares short (15 Apr 2024) 45.53M
Short ratio (15 Apr 2024) 41.94
Short % of float (15 Apr 2024) 415.98%
Short % of shares outstanding (15 Apr 2024) 410.61%
Shares short (prior month 15 Mar 2024) 43.55M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,055.89%

Management effectiveness

Return on assets (ttm)-29.62%
Return on equity (ttm)-60.80%

Income statement

Revenue (ttm)8.78M
Revenue per share (ttm)0.20
Quarterly revenue growth (yoy)-14.30%
Gross profit (ttm)N/A
EBITDA -112.3M
Net income avi to common (ttm)-104.7M
Diluted EPS (ttm)-2.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)201.39M
Total cash per share (mrq)4.35
Total debt (mrq)6.83M
Total debt/equity (mrq)4.28%
Current ratio (mrq)6.99
Book value per share (mrq)3.47

Cash flow statement

Operating cash flow (ttm)-81.07M
Levered free cash flow (ttm)-45.07M